Trexquant Investment LP - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$504,000
-16.0%
46,629
-14.5%
0.08%
+14.3%
Q1 2016$600,000
+25.0%
54,537
+11.5%
0.07%
+29.6%
Q2 2015$480,000
-8.0%
48,900
-17.1%
0.05%
+1.9%
Q1 2015$522,000
+255.1%
58,957
+250.9%
0.05%
+103.8%
Q4 2014$147,00016,8000.03%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders